Antiviral chemotherapy.
D000547:Amantadine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D003561:Cytarabine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004660:Encephalitis / Q000188:drug therapy; D006560:Herpes Labialis / Q000188:drug therapy; D006561:Herpes Simplex / Q000188:drug therapy; D014645:Herpesvirus 3, Human / Q000187:drug effects; D006801:Humans; D007065:Idoxuridine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D007251:Influenza, Human / Q000188:drug therapy; D007372:Interferons / Q000096:biosynthesis / Q000494:pharmacology / Q000627:therapeutic use*; D007635:Keratitis, Dendritic / Q000188:drug therapy; D012293:Rifampin / Q000627:therapeutic use*; D013882:Thiosemicarbazones / Q000009:adverse effects / Q000627:therapeutic use; D014615:Vaccinia / Q000188:drug therapy
D000998:Antiviral Agents; D007211:Indoles; D013882:Thiosemicarbazones; D003561:Cytarabine; D007372:Interferons; D000547:Amantadine; D007065:Idoxuridine; D012293:Rifampin